Fresh savings just popped up! 25% off 3 or more products. | Start Saving >>
12314
Basigin/EMMPRIN Antibody

Basigin/EMMPRIN Antibody #12314

This product is discontinued

We recommend the following alternatives

  • WB
  • IHC
H
Storage:

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Basigin/EMMPRIN Antibody recognizes endogenous levels of total Basigin/EMMPRIN protein. This antibody may cross-react with a protein of unknown origin at ~80 kDa in some cell lines.

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Val226 of human Basigin/EMMPRIN protein. Antibodies are purified by protein A and peptide affinity chromatography.

Basigin (EMMPRIN, CD147) is a type I integral membrane receptor protein belonging to the immunoglobulin superfamily (1). Basigin is a glycosylated protein with four known isoforms, of which isoform 2 is the most abundantly expressed (2). Multiple functions have been ascribed to Basigin; foremost among these is stimulating the secretion of extracellular matrix metalloproteinases by adjacent fibroblasts, a function which has been implicated in promoting tumor progression (2-4). Research studies have shown that Basigin is overexpressed by many tumor cells, and its expression level may correlate with tumor malignancy (5,6). A recent study identified the BASIGIN gene as a regulatory target of Slug, suggesting a role for Basigin in the process of epithelial-mesenchymal transition (7). Basigin has also been identified as a marker for a subset of highly suppressive regulatory T cells (8), and as an obligate receptor for the malarial parasite Plasmodium falciparum on human erythrocytes (9).

  1. Biswas, C. et al. (1995) Cancer Res 55, 434-9.
  2. Liao, C.G. et al. (2011) Mol Cell Biol 31, 2591-604.
  3. Sweeny, L. et al. (2012) Exp Cell Res 318, 1788-98.
  4. Lescaille, G. et al. (2012) BMC Cancer 12, 115.
  5. Piao, S. et al. (2012) J Cancer Res Clin Oncol 138, 627-35.
  6. Bi, X.C. et al. (2011) Clin Invest Med 34, E358.
  7. Wu, J. et al. (2011) Oncogene 30, 4410-27.
  8. Solstad, T. et al. (2011) Blood 118, 5141-51.
  9. Crosnier, C. et al. (2011) Nature 480, 534-7.
Entrez-Gene Id
682
Swiss-Prot Acc.
P35613
For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Upstream / Downstream

pathwayImage

Explore pathways related to this product.